Cilfa Opposition, Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz (Tdf/Ftc/Efv) , (P060102468)
No Annotations
Alert me when there are new annotations for this document
6 similar patent oppositions
-
Fundación GEP and Red Argentina de Personas Positivas opposition, tenofovir disoproxil fumarate/emtricitabine/efavirenz (TDF/FTC/EFV) , (AR 054060 A1)
Countries: Argentina Date: 2013
-
GTPI opposition, tenofovir disoproxil fumarate (TDF) , (PI9816239-0 (Divisional to PI9801145-4) )
Countries: Brazil Date: 2009
-
Cipla Ltd. opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (3383/DELNP/2005)
Countries: India Date: 2009
-
Intermed Labs opposition, tenofovir disoproxil fumarate (TDF) , (602/DEL/2007 (Divisional from 2076/DEL/1997))
Countries: India Date: 2009
-
Cipla Ltd. opposition, tenofovir disoproxil fumarate/emtricitabine/efavirenz (TDF/FTC/EFV) , (9661/DELNP/2007)
Countries: India Date: 2010
-
Fundación Grupo Efecto Positivo opposition, Tenofovir 300mg+ Emtricitabina 200mg (TDF+FTC), (n/a)
Countries: Argentina Date: 2015